New rapid tests aim to speed up ebola and lassa fever diagnosis
NCT ID NCT07681752
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study evaluates two new diagnostic tests (FORTIFIEDx and DECIPHER) for detecting Ebola and Lassa viruses. Researchers will use stored blood and cheek swab samples from patients in Guinea to see how well these tests compare to the standard PCR method. The goal is to determine if these faster, simpler tests can accurately identify infections, which could help in future outbreaks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FORTIFIEDx and DECIPHER bioassays (diagnostic tests using isothermal nucleic acid amplification)
What this could lead to
If accurate, these tests could enable faster, simpler diagnosis of Ebola and Lassa fever in remote areas, improving outbreak response.
What could go wrong
This is a retrospective study using stored samples, not a real-world test. The new tests may not perform as well in field conditions or detect all cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBOLA HEMORRHAGIC FEVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••